a developer of medical devices for cardiovascular and kidney diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with ANAB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then ANAB could also see price increases.
Ticker / NAME | Correlation To CRMD | 1D Price Change % | ||
---|---|---|---|---|
CRMD | 100% | -2.74% | ||
ANAB - CRMD | 39% Loosely correlated | -3.49% | ||
SAGE - CRMD | 32% Poorly correlated | N/A | ||
PGEN - CRMD | 31% Poorly correlated | -3.57% | ||
VERU - CRMD | 31% Poorly correlated | -6.62% | ||
ARCT - CRMD | 31% Poorly correlated | -2.04% | ||
More |
Ticker / NAME | Correlation To CRMD | 1D Price Change % |
---|---|---|
CRMD | 100% | -2.74% |
diseases theme (41 stocks) | 22% Poorly correlated | -1.18% |
cardiovascular theme (11 stocks) | 17% Poorly correlated | -0.69% |
medical research theme (126 stocks) | 16% Poorly correlated | -2.00% |
medical service theme (154 stocks) | 15% Poorly correlated | -2.06% |
medical devices theme (60 stocks) | 7% Poorly correlated | -1.98% |